References
- Gay S, Gay R E, Prochal J T. Immunohistological studies of bone marrow collagen. Myelofibrosis and the Biology of Connective Tissue, P D Berk, H Castro-Malaspina, L R Wasserman. Alan R. Liss Inc, New York 1984; 291–306
- Reilly J T, Nash J RG, Mackie M J, McVerry B A. Endothelial proliferation in myelofibrosis. Br J Haematol 1985; 60: 625–30
- Apaja-Sarkkinen M, Autio-Harmainen H, Alavaikko M, Risteli J, Risteli L. Immunohistochemical study of basement membrane proteins and type III procollagen in myelofibrosis. Br J Haematol 1986; 63: 571–80
- Reilly J T, Nash J RG, Mackie M J, McVerry B A. Immuno-enzymatic detection of fibronectin in normal and pathological haematopoietic tissue. Br J Haematol 1985; 59: 497–504
- Hochweiss S, Fruchtman S, Hahn E G, Gilbert H, Donovan P B, Johnson J, Goldberg J D, Berk P D. Increased serum procollagen III aminoterminal peptide in myelofibrosis. Am J Hematol 1983; 15: 343–51
- Vellenga E, Mulder N H, Van Zanten H K, Nieweg H O, Woldring M G. The significance of the aminoterminal propeptide of type III procollagen in paroxysmal nocturnal haemoglobinuria and myelofibrosis. Eur J Nucl Med 1983; 8: 499–501
- Arrago J F, Poirier O, Najeen Y. Evolution des polyglobulies primitives vers la myelofibrosis. Surveillance par le dosage de l‘amino-propeptide du’ procollagen III. Presse Med 1984; 13: 2429–32
- Hasselbalch H, Junker P, Lisse I, Bentsen K D. Serum procollagen III peptide in chronic myeloproliferative disorders. Scand J Haematol 1985; 35: 550–7
- Hasselbalch H, Junker P, Lisse I, Bentsen K D, Risteli L, Risteli J. Serum markers for type IV collagen and type III procollagen in the myelofibrosis-osteomyelosclerosis syndrome and other chronic myeloproliferative disorders. Am J Hematol 1986; 23: 101–11
- Ruoslahti E, Vaheri A. Novel human serum protein from fibroblast plasma membrane. Nature 1974; 248: 789–91
- Jaffe E A, Mosher D F. Synthesis of fibronectin by cultured human endothelial cells. J Exp Med 1978; 147: 1779–91
- Norfolk D R, Bowen M, Roberts B E, Child J A. Plasma fibronectin in myeloproliferative disorders and chronic granulocytic leukaemia. Br J Haematol 1983; 55: 319–24
- Vellenga E, Marrink J, Geest S, de Vries E GE. Plasma fibronectin in idiopathic myelofibrosis. Br J Haematol 1985; 60: 583–4
- Pettit J E, Lewis S M, Nicholas A W. Transitional myeloproliferative disorder. Br J Haematol 1979; 43: 167–84
- Laszlo J. Myeloproliferative disorders: Myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD and hemorrhagic thrombocythemia. Semin Hematol 1975; 12: 409–32
- Berlin N I. Diagnosis and classification of the polycythaemias. Semin Hematol 1975; 12: 339
- Galton D. The chronic leukaemia. Blood and Its Disorders, 2nd edn, R M Hardistry, D J Weatherall. Lippincot, Philadelphia 1982
- Eriksen H O, Clemmensen I, Hansen M S, Ibsen K K. Plasma fibronectin concentration in normal subjects. Scand J Clin Lab Invest 1982; 42: 291–5
- Laurell C B. Electroimmunoassay. Scand J Clin Lab Invest 1972; 29(Suppl. 124)
- Foster F N, Bowen M, Howdle P D, Losowsky M S. Low fibronectin in portal hypertension. Digestion 1983; 28: 122–4
- Söderstrom N, Bandmann U, Lundh B. Polycythaemia vera and myelofibrosis. Clin Haematol 1975; 4: 309–29, Pathoanatomical features of the spleen and liver Videbsk AA
- Owens M R, Cimino C D. Synthesis of fibronectin by the isolated perfused rat liver. Blood 1982; 59: 1305–9
- Gluud C, Dejgaard A, Clemmensen I. Plasma fibronectin in patients with liver diseases. Scand J Clin Lab Invest 1983; 43: 533–7
- Saba T M, Jaffe E. Plasma fibronectin (opsonic glycoprotein); its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticulo-endothelial function. Am J Med 1980; 68: 577–94
- Mosher D F, Williams E M. Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation. J Lab Clin Med 1978; 91: 729–35
- Pott G, Voss B, Lohmann J, Zundorf P. Loss of fibronectin in plasma of patients with shock and septicaemia and after haemoperfusion in patients with severe poisoning. J Clin Chem Clin Biochem 1982; 20: 333–5